Imaging and targeted agents in gastrointestinal cancers: overview on perfusion- and diffusion-weighted magnetic resonance imaging and angiogenesis inhibitors
- 15 March 2008
- journal article
- Published by Springer Nature in Targeted Oncology
- Vol. 3 (2) , 101-110
Abstract
No abstract availableKeywords
This publication has 47 references indexed in Scilit:
- Noninvasive monitoring of radiation-induced treatment response using proton magnetic resonance spectroscopy and diffusion-weighted magnetic resonance imaging in a colorectal tumor modelRadiotherapy and Oncology, 2007
- Antiangiogenics: The Potential Role of Integrating This Novel Treatment Modality With Chemoradiation for Solid CancersJournal of Clinical Oncology, 2007
- Diffusion-Weighted MRI in the Body: Applications and Challenges in OncologyAmerican Journal of Roentgenology, 2007
- Predicting Response of Colorectal Hepatic Metastasis: Value of Pretreatment Apparent Diffusion CoefficientsAmerican Journal of Roentgenology, 2007
- DCE-MRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agentsBritish Journal of Cancer, 2007
- Combined Vascular Endothelial Growth Factor–Targeted Therapy and Radiotherapy for Rectal Cancer: Theory and Clinical PracticeSeminars in Oncology, 2006
- Recent Chemotherapy Reduces the Sensitivity of [18F]Fluorodeoxyglucose Positron Emission Tomography in the Detection of Colorectal MetastasesJournal of Clinical Oncology, 2005
- Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic TherapyScience, 2005
- MRI for assessing antivascular cancer treatmentsBritish Journal of Radiology, 2003
- Measuring the clinical response. What does it mean?European Journal of Cancer, 2002